High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma
(Q72274191)
scientific article published on 01 March 1994
scientific article published on 01 March 1994
Language:
Current Data About
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma
other details
| description | scientific article published on 01 March 1994 |
External Links
| (P356) |
10.1200/JCO.1994.12.3.503
|
| (P698) |
8120548
|